Children's Health

COSA ASM 2007 Highlights
Bone 16 Nov 2007

COSA ASM 2007 Highlights

The 34th COSA ASM offered a series of stimulating and exciting presentations from international and national experts covering the many disciplines of oncology research and clinical practice. The conference was held at the Adelaide Convention Centre on November 14-16, 2007. Some of the presentations that took place are summarised here.
Link between Asthma and Depressive and Anxiety Disorders
Children's health 16 Nov 2007

Link between Asthma and Depressive and Anxiety Disorders

Young people with asthma are about twice as likely to suffer from depressive and anxiety disorders than are children without asthma, according to a study by a research team in Seattle. Previous research had suggested a possible link in young people between asthma and some mental health problems, such as…
Young Cancer Patients Failing to Receive the Best Cancer Treatment
Blood 16 Nov 2007

Young Cancer Patients Failing to Receive the Best Cancer Treatment

Adolescent and young adult cancer patients are experiencing a reduced survival rate because they are failing to be involved in clinical trials, a meeting of national cancer experts will hear today. The UK Teenage Cancer Trust’s visiting professor, Dr David Walker, said young people who did take part in medical…
New Anti-cancer Drug Now Subsidised by the Government
Blood 16 Nov 2007

New Anti-cancer Drug Now Subsidised by the Government

A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme (PBS). Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Although the treatment is worth several thousands of dollars, patients can now access the drug at heavily…
New Hope for Patients with Myeloma as Velcade is Added to the PBS
Blood 16 Nov 2007

New Hope for Patients with Myeloma as Velcade is Added to the PBS

A novel therapy for advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme from November 1st 2007. This is fantastic news for sufferers of this rare and debilitating haematological cancer, whom normally face a poor prognosis without treatment. Multiple myeloma (MM) is a…
Food Allergies among College Students: Awareness and Preparedness are Low
Children's health 13 Nov 2007

Food Allergies among College Students: Awareness and Preparedness are Low

In one of the few studies ever to focus on food allergies among college students, University of Michigan Health System researchers have found that a surprising number of these young adults are not prepared to rapidly treat themselves in case of an allergic reaction and often are not vigilant about…
The Power of Fruit Juice
Children's health 13 Nov 2007

The Power of Fruit Juice

Some types of fruit juice are packed with health benefits, but stay away from juices loaded with sugar. In years past, family physician Pamela Rockwell told parents not to let their children drink too much fruit juice because of its link to obesity. These days, though, she has changed her…
Significant Shift in Reason for Tonsillectomies over Last 35 Years
Children's health 13 Nov 2007

Significant Shift in Reason for Tonsillectomies over Last 35 Years

A new Mayo Clinic study indicates tonsillectomies are increasingly being performed to treat airway obstructions evidenced by snoring and sleep disorders as opposed to tonsil infections. “This research shows that obstructive airway problems causing sleep-disordered breathing are now the primary reason children and young adults are having their tonsils and…
New Anti-cancer Drug now Subsidised by the Government
Blood 13 Nov 2007

New Anti-cancer Drug now Subsidised by the Government

A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme. Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Until recently this drug was at prices far beyond what the average Australian could afford. Now the public…